CLEAR LABELS Act

The CLEAR LABELS Act aims to increase transparency in the drug supply chain by requiring more detailed information on pharmaceutical labels. It mandates that finished drug products' labels, or linked electronic portals, include the name, location, and unique identifier of the manufacturer, packer, or distributor. Additionally, labels must identify the original manufacturer of both the finished drug product and each active pharmaceutical ingredient, with this information also available in paper form upon request. The bill further exempts finished drug products from standard customs country-of-origin marking if they comply with these new labeling requirements.